Position in AMLX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$2,750,698
+$352,722 QoQ
Shares Held
197,892
-0.3% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
2.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Aldebaran Capital, LLC holds $2,750,698 across 1 Drug Manufacturers - Specialty & Generic name. AMLX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
197,892 | $2,750,698 |
All Filings in AMLX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,750,698 | 197,892 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,397,976 | 198,508 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,778,801 | 204,474 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,396,271 | 217,827 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $917,755 | 259,253 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $993,206 | 262,753 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $874,161 | 269,803 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $512,625 | 269,803 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||